Embargo FOR RELEASE on Tuesday, Feb 15th, 2022 IMBED’S MICROLYTE MATRIX ADDED TO VA’S IDIQ CONTRACT February 15, 2022 (Madison, WI) – Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical, a veteran-owned Federal Contractor with fourteen years of… Read More »IMBED’S MICROLYTE MATRIX ADDED TO VA’S IDIQ CONTRACT
Madison, WI — 10 November 2021 – Imbed Biosciences, Inc. announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version… Read More »Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
Madison, WI, October 4, 2021 – Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and… Read More »Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection
Madison, WI, October 14th, 2021 – Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded $800,000 in a Commercialization Readiness Pilot (CRP) grant by the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support late-stage development of a next-generation wound… Read More »NIH Awards Imbed Biosciences $800K SBIR Grant to Kill Bacteria in Biofilms
Madison, WI, October 12th, 2021 – Imbed Biosciences is proud to announce that research conducted using Microlyte Matrix and Microlyte Surgical will be presented in a panel discussion at SAWC, a national wound healing conference. Imbed Biosciences announced today that clinical results documenting the use… Read More »Microlyte® Matrix and Microlyte® Surgical featured in clinical research presented at SAWC
JULY 14th, 2021 Imbed Biosciences has signed an agreement with Spartan Medical to service government customers. Read the press release here: https://www.imbedbio.com/wp-content/uploads/2021/07/PR21-01-Spartan-Med.pdf About Imbed Biosciences, Inc. Imbed is a privately held biotech company registered with FDA as a medical device manufacturer with an ISO 13485… Read More »Agreement Signed with Spartan Medical
Madison, WI, April 14, 2021 – Imbed Biosciences is proud to announce that its animal health product, MicroLyte® Vet, is now available in Canada through McCarthy and Sons Service. McCarthy & Sons Service is a full-service veterinary marketing, supply, and distribution company. Their team of… Read More »MicroLyte® Vet Now Available in Canada
Madison, WI, December 15, 2020 – Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the advanced wound care, announced today that it has entered an exclusive distribution agreement with Jorgensen Laboratories (“Jorvet”) to distribute its MicroLyte® VET wound dressings… Read More »Imbed Bio Partners with Jorvet for Master Distribution of MicroLyte® VET Wound Dressings
MADISON, WI, NOVEMBER 13, 2020 (BUSINESS WIRE) Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte® Matrix, in complex chronic wounds.… Read More »Next-Generation Wound Dressing Microlyte Matrix Heals a Majority of Chronic Wounds in a First Published Prospective Clinical Study
MADISON, WI, DECEMBER 6, 2019 (via BUSINESS WIRE) Imbed Biosciences Inc. (Imbed), a privately-held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers, and surgical wounds, announced today the launch of its new corporate and product brand identities,… Read More »Imbed Biosciences Reveals New Brand Identity for Company and Flagship Product Microlyte® Matrix for Wound Care